# ELVN (Enliven Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Enliven Therapeutics, Inc. reported $897.2M in total assets and a net loss of $113.5M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/ELVN
- Markdown: https://convexityos.com/fundamentals/ELVN.md
- SEC CIK: 0001672619
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:18 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001672619&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$135.4M | Operating profit |
| Net Income | FY 2025 | -$113.5M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$1.46 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$66.41M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $884.4M | Total debt: $1.31M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $85.86M | $80.78M | $64.57M | $31.02M | $38.44M | $32.15M | $19.01M |
| Total Operating Expenses | $119.7M | $104.6M | $83.53M | $38.79M | $51.44M | $41.70M | $24.12M |
| **Operating Income** | -$119.7M | -$104.6M | -$83.53M | -$38.79M | -$51.44M | -$41.70M | -$24.12M |
| **EBITDA** | -$119.4M | -$104.3M | -$83.23M | -$38.59M | -$51.34M | -$41.60M | -$24.08M |
| Income Before Tax | -- | -- | -- | $1.58M | -$51.38M | -- | -- |
| Income Tax Expense | $0 | $232K | $0 | $0 | -- | -- | -- |
| **Net Income** | -$103.7M | -$89.02M | -$71.58M | -$37.66M | -$51.38M | -$41.36M | -$23.46M |
| Basic EPS | -$1.83 | -$1.89 | -$2.01 | -$12.05 | -$20.29 | -$30.22 | -$285.96 |
| **Diluted EPS** | -$1.83 | -$1.89 | -$2.01 | -$12.05 | -$20.29 | -$30.22 | -$285.96 |
| Basic Shares Outstanding | 56.7M | 47.1M | 35.5M | 3.1M | 2.5M | 1.6M | 82.0K |
| Diluted Shares Outstanding | 56.7M | 47.1M | 35.5M | 3.1M | 2.5M | 1.6M | 82.0K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $28.02M | $29.00M | $20.69M | $21.25M | $18.23M | $21.49M | $24.89M | $20.72M |
| Total Operating Expenses | $36.05M | $37.21M | $27.82M | $34.28M | $25.10M | $28.58M | $31.69M | $26.90M |
| **Operating Income** | -$36.05M | -$37.21M | -$27.82M | -$34.28M | -$25.10M | -$28.58M | -$31.69M | -$26.90M |
| **EBITDA** | -$36.03M | -$37.20M | -$27.81M | -$34.20M | -$25.03M | -$28.50M | -$31.62M | -$26.83M |
| Income Tax Expense | -- | -- | -- | -- | $0 | $0 | -- | -- |
| **Net Income** | -$27.70M | -$32.48M | -$23.63M | -$29.67M | -$20.15M | -$25.34M | -$28.54M | -$23.18M |
| Basic EPS | -$0.36 | -$0.49 | -$0.38 | -- | -$0.32 | -$0.49 | -$0.57 | -- |
| **Diluted EPS** | -$0.36 | -$0.49 | -$0.38 | -- | -$0.32 | -$0.49 | -$0.57 | -- |
| Basic Shares Outstanding | 78.0M | 66.2M | 62.8M | -- | 62.1M | 52.1M | 50.1M | -- |
| Diluted Shares Outstanding | 78.0M | 66.2M | 62.8M | -- | 62.1M | 52.1M | 50.1M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $98.90M | $124.1M | $100.1M | $75.54M | $48.31M | $47.70M | $4.94M |
| Short-Term Investments | $363.7M | $189.3M | $153.0M | $0 | $41.97M | $40.52M | $23.97M |
| **Cash & Short-Term Investments** | $462.6M | $313.4M | $253.1M | $75.54M | $90.30M | $88.20M | $28.91M |
| **Total Current Assets** | $474.9M | $318.1M | $266.2M | $77.75M | $92.70M | $90.41M | $30.62M |
| Property, Plant & Equipment, Net | $34K | $458K | $742K | $890K | $250K | $349K | $442K |
| Long-Term Investments | -- | -- | -- | $0 | -- | -- | -- |
| Other Non-Current Assets | $656K | $7.17M | $4.09M | $0 | $175K | $88K | $2.23M |
| **Total Non-Current Assets** | $1.29M | $7.63M | $5.72M | $5.54M | $950K | $437K | $2.67M |
| **Total Assets** | $476.2M | $325.8M | $271.9M | $83.30M | $93.65M | $90.84M | $33.30M |
| Accounts Payable | $2.16M | $1.34M | $532K | $3.44M | $2.36M | $1.97M | $1.66M |
| **Total Current Liabilities** | $16.57M | $15.91M | $25.89M | $9.71M | $7.21M | $6.25M | $4.20M |
| Other Non-Current Liabilities | $0 | $0 | $67K | $659K | -- | -- | -- |
| **Total Non-Current Liabilities** | $0 | $0 | $67K | $659K | $406K | $160K | $184K |
| **Total Liabilities** | $16.57M | $15.91M | $25.96M | $10.37M | $7.62M | $6.41M | $4.38M |
| **Total Debt (incl. Leases)** | $399K | -- | $335K | -- | $652K | -- | -- |
| Common Stock | $59K | $49K | $41K | $1.0K | $27K | $18K | $1.0K |
| Retained Earnings | -$347.2M | -$243.5M | -$154.4M | -$82.86M | -$147.5M | -$96.11M | -$54.75M |
| Accumulated Other Comp. Income | $334K | $55K | $141K | $0 | -$16K | $4.0K | $32K |
| **Total Stockholders' Equity** | $459.6M | $309.8M | $245.9M | -$76.83M | -$42.89M | $84.44M | -$48.85M |
| Total Equity | $459.6M | $309.8M | $245.9M | -$76.83M | -$42.89M | $84.44M | -$48.85M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $151.7M | $135.5M | $132.2M | $98.90M | $101.7M | $119.4M | $101.7M | $124.1M |
| Short-Term Investments | $732.7M | $759.6M | $320.2M | $363.7M | $375.8M | $371.1M | $187.8M | $189.3M |
| **Cash & Short-Term Investments** | $884.4M | $895.2M | $452.4M | $462.6M | $477.6M | $490.5M | $289.6M | $313.4M |
| **Total Current Assets** | $894.8M | $907.3M | $463.1M | $474.9M | $482.7M | $495.6M | $294.3M | $318.1M |
| Property, Plant & Equipment, Net | $201K | $140K | $20K | $34K | $399K | $462K | $404K | $458K |
| Other Non-Current Assets | $962K | $1.24M | $1.19M | $656K | $7.10M | $7.24M | $7.20M | $7.17M |
| **Total Non-Current Assets** | $2.47M | $2.88M | $1.72M | $1.29M | $8.19M | $8.27M | $8.25M | $7.63M |
| **Total Assets** | $897.2M | $910.2M | $464.9M | $476.2M | $490.9M | $503.9M | $302.6M | $325.8M |
| Accounts Payable | $2.73M | $371K | $1.64M | $2.16M | $1.43M | $2.35M | $1.56M | $1.34M |
| **Total Current Liabilities** | $19.47M | $14.16M | $11.49M | $16.57M | $14.65M | $15.21M | $13.97M | $15.91M |
| Other Non-Current Liabilities | $805K | $913K | -- | $0 | $103K | $204K | $302K | $0 |
| **Total Non-Current Liabilities** | $805K | $913K | $0 | $0 | $103K | $204K | $302K | $0 |
| **Total Liabilities** | $20.28M | $15.07M | $11.49M | $16.57M | $14.75M | $15.41M | $14.27M | $15.91M |
| **Total Debt (incl. Leases)** | $1.31M | $1.51M | $302K | $399K | $490K | $580K | $667K | -- |
| Common Stock | $74K | $73K | $61K | $59K | $59K | $59K | $49K | $49K |
| Retained Earnings | -$431.0M | -$403.3M | -$370.8M | -$347.2M | -$317.5M | -$297.4M | -$272.0M | -$243.5M |
| Accumulated Other Comp. Income | -$3.51M | -$1.91M | -$382K | $334K | $221K | -$177K | -$16K | $55K |
| **Total Stockholders' Equity** | $876.9M | $895.1M | $453.4M | $459.6M | $476.1M | $488.5M | $288.3M | $309.8M |
| Total Equity | $876.9M | $895.1M | $453.4M | $459.6M | $476.1M | $488.5M | $288.3M | $309.8M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$103.7M | -$89.02M | -$71.58M | -$37.66M | -$51.38M | -$41.36M | -$23.46M |
| Depreciation & Amortization | $300K | $300K | $300K | $200K | $99K | $97K | $33K |
| Stock-Based Compensation | $34.02M | $20.17M | $12.91M | $3.19M | $3.85M | $2.23M | $899K |
| Change in Payables | $817K | $810K | -$2.25M | $411K | $389K | $313K | $750K |
| **Operating Cash Flow** | -$70.30M | -$73.19M | -$61.27M | -$32.08M | -$46.77M | -$37.40M | -$21.88M |
| Capital Expenditure | -$158K | -$44K | -$149K | -$612K | -$12K | -$18K | -$140K |
| **Free Cash Flow** | -$70.46M | -$73.24M | -$61.42M | -$32.69M | -$46.78M | -$37.42M | -$22.02M |
| Purchases of Investments | -$446.8M | -$350.7M | -$268.3M | $0 | -- | -- | -- |
| **Investing Cash Flow** | -$173.8M | -$36.00M | -$148.4M | -$612K | -$1.63M | -$16.72M | -$24.06M |
| Common Stock Issued | -- | $0 | $161.4M | $0 | -- | -- | -- |
| **Financing Cash Flow** | $218.9M | $133.2M | $234.3M | -$1.80M | $49.10M | $96.88M | $43.58M |
| **Net Change in Cash** | -$25.27M | $23.98M | $24.61M | -$34.49M | $698K | $42.76M | -$2.36M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$27.70M | -$32.48M | -$23.63M | -$29.67M | -$20.15M | -$25.34M | -$28.54M | -$23.18M |
| Depreciation & Amortization | $13K | $7.0K | $14K | $83K | $62K | $81K | $74K | $63K |
| Stock-Based Compensation | $8.06M | $13.91M | $7.40M | $12.31M | $7.18M | $7.72M | $6.80M | $5.34M |
| Change in Payables | $2.59M | -$1.50M | -$519K | $828K | -$1.02M | $789K | $220K | $323K |
| **Operating Cash Flow** | -$12.55M | -$18.53M | -$19.29M | -$15.84M | -$13.28M | -$17.06M | -$24.13M | -$17.20M |
| Capital Expenditure | -$94K | -$99K | $0 | $0 | $1.0K | -$139K | -$20K | $0 |
| **Free Cash Flow** | -$12.65M | -$18.63M | -$19.29M | -$15.84M | -$13.28M | -$17.20M | -$24.15M | -$17.20M |
| Purchases of Investments | -$45.97M | -$560.2M | -$65.84M | -$75.52M | -$71.86M | -$240.2M | -$59.23M | -$116.5M |
| **Investing Cash Flow** | $26.33M | -$441.6M | $42.53M | $12.38M | -$4.06M | -$183.6M | $1.43M | $727K |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Financing Cash Flow** | $2.39M | $463.4M | $10.05M | $623K | -$368K | $218.4M | $234K | $39.97M |
| **Net Change in Cash** | $16.16M | $3.32M | $33.29M | -$2.84M | -$17.70M | $17.73M | -$22.47M | $23.50M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -22.6% | -28.7% | -29.1% | -- | -- | -49.0% | -- |
| Return on Assets (ROA) | -21.8% | -27.3% | -26.3% | -45.2% | -54.9% | -45.5% | -70.5% |
| Current Ratio | 28.66x | 19.99x | 10.28x | 8.00x | 12.86x | 14.47x | 7.29x |
| Quick Ratio | 27.92x | 19.69x | 9.77x | 7.78x | 12.52x | 14.12x | 6.89x |
| Debt to Equity | 0.00x | -- | 0.00x | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -12.9% | -11.8% | -21.8% | -22.6% | -20.4% | -20.5% | -32.9% | -28.7% |
| Return on Assets (ROA) | -12.6% | -11.6% | -21.2% | -21.8% | -19.8% | -19.9% | -31.3% | -27.3% |
| Current Ratio | 45.95x | 64.07x | 40.32x | 28.66x | 32.95x | 32.58x | 21.06x | 19.99x |
| Quick Ratio | 45.42x | 63.22x | 39.38x | 27.92x | 32.60x | 32.25x | 20.73x | 19.69x |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
